Target intelligence / Profile preview

ATPase copper transporting beta (ATP7B) (ATP7B)

Target
ATP7B
Molecular classification
P-type ATPase [6, 11], Cation transporter [11], Enzyme [15], Transporter [14]
01

Overview

ATPase copper transporting beta (ATP7B), also known as the Wilson disease protein, is a P-type ATPase primarily expressed in the liver that plays a central role in copper homeostasis [6, 11]. It functions by transporting copper from the cytosol into the trans-Golgi network for incorporation into ceruloplasmin and by facilitating the excretion of excess copper into the bile via vesicular trafficking [6, 15]. Mutations in the ATP7B gene lead to Wilson disease, a rare autosomal recessive disorder characterized by toxic copper accumulation in the liver, brain, and other tissues, resulting in hepatic cirrhosis and neuropsychiatric symptoms [5, 11]. In the context of oncology, ATP7B is a significant mediator of resistance to platinum-based chemotherapies, such as cisplatin and carboplatin, as it can sequester and efflux these agents from cancer cells [1, 3]. Current therapeutic interventions for Wilson disease include copper chelators like penicillamine and trientine, as well as zinc salts that block intestinal copper absorption [9, 10]. Emerging therapies include gene replacement strategies using adeno-associated virus (AAV) vectors to restore functional ATP7B expression in the liver [8]. Additionally, targeting ATP7B in cancer is being investigated as a strategy to overcome drug resistance and improve the efficacy of platinum-based treatments [1, 2].

Other names
Copper-transporting ATPase 2Wilson disease-associated proteinWNDPWDWC1Copper pump 2ATPase, Cu++ transporting, beta polypeptideATPase copper transporting polypeptide beta
02

Mechanism of action

In Wilson disease, therapeutic strategies focus on copper removal via chelation (e.g., penicillamine) or blocking intestinal absorption via zinc salts; gene therapies aim to restore functional ATP7B protein expression in hepatocytes [8, 10]. In oncology, ATP7B inhibition (e.g., via siRNA) is used to prevent the sequestration and efflux of platinum-based drugs, thereby increasing intracellular drug concentration and sensitizing cancer cells to chemotherapy [1, 3].

03

Biological functions

Copper homeostasis [9, 11]Biliary copper excretion [6, 11]Ceruloplasmin synthesis [6, 15]Intracellular trafficking [13, 16]
04

Disease associations

Wilson disease [5, 6, 11]Ovarian cancer [1, 3]Prostate cancer [2]Liver cirrhosis [5, 15]
05

Safety considerations

Neurological worsening upon initiation of chelation [5, 10]Nephrotoxicity and hypersensitivity (Penicillamine) [10]Copper deficiency (hypocupremia) [9]Immune response to AAV vectors [8]
06

Interacting drugs

Penicillamine [10]

8 more in the full profile.

07

Biomarkers

Serum ceruloplasmin [5, 15]24-hour urinary copper [13, 15]Hepatic copper concentration [11, 15]Kayser-Fleischer rings [5, 15]ATP7B gene mutations [6, 11]

Beyond the preview

Go deeper on ATPase copper transporting beta (ATP7B) (ATP7B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATPase copper transporting beta (ATP7B) (ATP7B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call